Alibaba Group Holding (NYSE:BABA) slashed its large language model prices by up to 85%, exhibiting intense domestic rivalry ...

Alibaba to sell stake in China's hypermarket chain Sun Art. Brand prescription drugs to rise an average 4.5% in 2025.

Alibaba said late Wednesday it would sell its entire stake in Sun Art to Chinese private-equity firm DCP Capital Partners for up to the equivalent of $1.58 billion. An Alibaba-affiliated company, New ...

The first trading day of 2025 is here, and investors are expecting a chaotic start. After a volatile close to 2024, global ...

Thomas Chong, a Hong Kong-based analyst at investment bank Jefferies, says Alibaba’s disposal had already been expected by ...

Gain insight on CyberArk Software, Tesla, Kuaishou Technology and more in the latest Market Talks covering Technology, Media ...

China’s e-commerce pioneer expects gross proceeds of up to HK$12.3 billion (US$1.6 billion or $2.15 billion) from selling its ...

Grab has acquired the operations of Nham24, a leading food delivery platform in Cambodia, following regulatory approval. This ...

Brands are skittish about appearing near stories on politics and violence, but news outlets say their fears are overblown. A regulatory filing shows Buffett has raised his stake in ...

A brilliant start, a saggy middle and then a flat thud — but an astounding finish, nonetheless — that was the trajectory of ...

Once a Wall Street favorite and a leader in China's e-commerce, Alibaba is facing challenges in growing its revenue. The company is losing some of its market share amid a slowing Chinese economy and ...

Alibaba announced significant price reductions of up to 85% for its large language models (LLMs), signaling intensifying ...